Ultragenyx Pharmaceutical is a biopharmaceutical company that develops and commercializes treatments for rare and ultra-rare genetic diseases. Its portfolio includes enzyme replacement therapies and other medicines aimed at metabolic disorders, bone conditions and disorders of the central nervous system. The company serves patients and specialist physicians through its own commercial operations and partnerships, and it is based in Novato, California, in the United States.
Ultragenyx Pharmaceutical Inc. trades under the code 0LIF on the London Exchange in UK, with its price quoted in US dollars (USD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #3633 of 3787 on the London Exchange · confidence Medium
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendWeak
8/100
Below its long-term averages and far from its highs.
See the numbers →
Above 200-day average-32.1%
From 52-week high-57.6%
MomentumWeak
6/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-43.1%
6-month return-35.0%
Stability (higher is calmer)Weak
8/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)102.0%
Worst drawdown, 1 year (smaller is calmer)-65.1%
LiquidityWeak
42/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.35M USD
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 12.87 – 41.50Daily closes, split-adjusted
Signals
50-day average17.92
200-day average23.10
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.86
Technical summary
Daily
Neutral
5 bullish · 3 neutral · 7 bearish
Weekly
Strongly bearish
0 bullish · 1 neutral · 6 bearish
Monthly
Strongly bearish
0 bullish · 0 neutral · 1 bearish
Moving averages (daily)
SMA 10
15.38
Bullish
EMA 10
15.49
Bullish
SMA 20
15.14
Bullish
EMA 20
15.54
Bullish
SMA 50
17.92
Bearish
EMA 50
17.77
Bearish
SMA 100
23.05
Bearish
EMA 100
20.59
Bearish
SMA 200
23.10
Bearish
EMA 200
–
n/a
Oscillators (daily)
RSI (14)
47.92
Neutral
MACD (12, 26)
-0.41
Bearish
Momentum (12)
5.31
Bullish
Stochastic %K (14)
72.52
Neutral
Williams %R (14)
-27.48
Neutral
CCI (20)
117.5
Bearish
Pivot points (classic, last session)
S3
14.94
S2
15.21
S1
15.45
Pivot
15.72
R1
15.96
R2
16.23
R3
16.47
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in USD. Educational only, not financial advice.
